NCT04953754View on ClinicalTrials.gov

Melatonin and Vaccine Response, Immunity, and Chronobiology Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Vaccine ResponseSleepCircadian Rhythm Disorders
Interventions
DIETARY_SUPPLEMENT

Melatonin

The melatonin group will receive 5mg melatonin nightly

DEVICE

Phillips Actiwatch Spectrum Plus

Both groups will be monitored by the FDA-cleared Actigraph

Trial Locations (1)

20889

Naval Support Activity, Bethesda

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

lead

Walter Reed National Military Medical Center

FED

NCT04953754 - Melatonin and Vaccine Response, Immunity, and Chronobiology Study | Biotech Hunter | Biotech Hunter